Phase II Trial of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment - Related Studies

Phase II Trial of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment (AMBIZYGO)

This study is not yet open for participant recruitment.

Study NCT00467883. Last updated on April 30, 2007. Information provided by Assistance Publique - Hôpitaux de Paris

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Zygomycosis

2	More general conditions related to this trial
		Mycoses

3	Interventions listed in this trial
		Liposomal Amphotericin B

4	Additional drug interventions recognized in this trial
		Abelcet
		AmBisome
		Amphotericin B

5	More general drug interventions related to this trial
		Amebicides
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antibiotics, Antifungal
		Antifungal Agents
		Antiparasitic Agents
		Antiprotozoal Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Assistance Publique - Hôpitaux de Paris